Medicine
Hydrochlorothiazide 12.5 mg capsule
Hydrochlorothiazide 12.5 mg capsule is a generic prescription medicine for oral use, made by 19 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from light, moisture, freezing, -20°C (-4°F). Store at 20°- 25°C…
Key facts
- Active ingredient (INN)
- Hydrochlorothiazide
- Brand
- Sold under the generic name
- Strength
- 12.5 mg
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 10 blister pack, 30 capsules, 100 capsules and 114 more
- Manufacturers
- Alembic PharmaceuticalsIndiaAurobindo PharmaIndiaUnichem LaboratoriesIndiaBryant Ranch PrepackScieGen PharmaceuticalsRising Pharma HoldingsActavis Pharma19 labelers on the register
- Origin register
- US FDA, United States
- Storage
- Protect from light, moisture, freezing, -20°C (-4°F). Store at 20°- 25°C (68°-77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C03AA03 Hydrochlorothiazide
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 27 December 1996
- Identifiers
- RxCUI 199903DailyMed set ID c1052d38-fd75-40c2-a685-0e889009be0b, 45316037-52ec-438f-8780-b2e983fef3f5, a3eb7294-f913-434b-896c-da028bfebc73 +32NDC 63187-548, 72162-1528, 0591-0347 +32Application NDA020504, ANDA203561, ANDA078164 +2
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
A sample of 40 packs from 19 labelers. The register lists 117 packs for this generic presentation, and we confirm the exact pack on the quote.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 46708-438-10 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 30 capsule in 1 bottle | 46708-438-30 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 100 capsule in 1 bottle | 46708-438-31 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 500 capsule in 1 bottle | 46708-438-71 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 1000 capsule in 1 bottle | 46708-438-91 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 10 blister pack in 1 carton / 10 capsule in 1 blister pack | 62332-070-10 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 30 capsule in 1 bottle | 62332-070-30 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 100 capsule in 1 bottle | 62332-070-31 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 500 capsule in 1 bottle | 62332-070-71 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 1000 capsule in 1 bottle | 62332-070-91 | Alembic PharmaceuticalsIndia | 2 March 2017 |
| 100 capsule in 1 bottle | 65862-113-01 | Aurobindo PharmaIndia | 19 September 2007 |
| 500 capsule in 1 bottle | 65862-113-05 | Aurobindo PharmaIndia | 19 September 2007 |
| 300 capsule in 1 bottle | 65862-113-33 | Aurobindo PharmaIndia | 19 September 2007 |
| 1000 capsule in 1 bottle | 65862-113-99 | Aurobindo PharmaIndia | 19 September 2007 |
| 100 capsule in 1 bottle, plastic | 29300-130-01 | Unichem LaboratoriesIndia | 15 March 2010 |
| 500 capsule in 1 bottle, plastic | 29300-130-05 | Unichem LaboratoriesIndia | 15 March 2010 |
| 1000 capsule in 1 bottle, plastic | 29300-130-10 | Unichem LaboratoriesIndia | 15 March 2010 |
| 100 capsule, gelatin coated in 1 bottle | 0591-0347-01 | Actavis Pharma | 27 December 1996 |
| 500 capsule, gelatin coated in 1 bottle | 0591-0347-05 | Actavis Pharma | 27 December 1996 |
| 100 capsule in 1 bottle | 57237-002-01 | Rising Pharma Holdings | 19 September 2007 |
| 500 capsule in 1 bottle | 57237-002-05 | Rising Pharma Holdings | 19 September 2007 |
| 1000 capsule in 1 bottle | 57237-002-99 | Rising Pharma Holdings | 19 September 2007 |
| 100 capsule in 1 bottle | 50228-146-01 | ScieGen Pharmaceuticals | 14 January 2019 |
| 500 capsule in 1 bottle | 50228-146-05 | ScieGen Pharmaceuticals | 14 January 2019 |
| 1000 capsule in 1 bottle | 50228-146-10 | ScieGen Pharmaceuticals | 14 January 2019 |
| 30 capsule in 1 bottle | 50228-146-30 | ScieGen Pharmaceuticals | 14 January 2019 |
| 500 capsule in 1 bottle | 63629-8498-1 | Bryant Ranch Prepack | 18 May 2021 |
| 30 capsule in 1 bottle | 71335-0067-1 | Bryant Ranch Prepack | 3 April 2018 |
| 10 capsule in 1 bottle | 71335-0067-2 | Bryant Ranch Prepack | 29 May 2024 |
| 90 capsule in 1 bottle | 71335-0067-3 | Bryant Ranch Prepack | 3 April 2018 |
| 100 capsule in 1 bottle | 71335-0067-4 | Bryant Ranch Prepack | 12 August 2020 |
| 60 capsule in 1 bottle | 71335-0067-5 | Bryant Ranch Prepack | 29 May 2024 |
| 120 capsule in 1 bottle | 71335-0067-6 | Bryant Ranch Prepack | 6 August 2020 |
| 7 capsule in 1 bottle | 71335-0067-7 | Bryant Ranch Prepack | 29 May 2024 |
| 15 capsule in 1 bottle | 71335-0067-8 | Bryant Ranch Prepack | 29 May 2024 |
| 14 capsule in 1 bottle | 71335-0067-9 | Bryant Ranch Prepack | 5 March 2021 |
| 30 capsule in 1 bottle | 71335-0770-1 | Bryant Ranch Prepack | 13 April 2018 |
| 10 capsule in 1 bottle | 71335-0770-2 | Bryant Ranch Prepack | 7 May 2018 |
| 90 capsule in 1 bottle | 71335-0770-3 | Bryant Ranch Prepack | 10 April 2018 |
| 100 capsule in 1 bottle | 71335-0770-4 | Bryant Ranch Prepack | 1 October 2018 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 12 February 1959 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Hydrochlorothiazide
Clinical summary
Hydrochlorothiazide is a thiazide diuretic indicated in the management of hypertension either as the sole therapeutic agent, or in combination with other antihypertensives. It is available as tablets, capsules and oral solution. MedsAcross supplies Hydrochlorothiazide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about HydrochlorothiazideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Hydrochlorothiazide prescribing information (Actavis Pharma) · U.S. National Library of Medicine, DailyMed
Need Hydrochlorothiazide 12.5 mg capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.